Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - AVEO PHARMACEUTICALS, INC. | aveo-ex322_12.htm |
| EX-32.1 - EX-32.1 - AVEO PHARMACEUTICALS, INC. | aveo-ex321_14.htm |
| EX-31.2 - EX-31.2 - AVEO PHARMACEUTICALS, INC. | aveo-ex312_10.htm |
| EX-31.1 - EX-31.1 - AVEO PHARMACEUTICALS, INC. | aveo-ex311_11.htm |
| EX-23.1 - EX-23.1 - AVEO PHARMACEUTICALS, INC. | aveo-ex231_7.htm |
| EX-10.17 - EX-10.17 - AVEO PHARMACEUTICALS, INC. | aveo-ex1017_389.htm |
| EX-10.16 - EX-10.16 - AVEO PHARMACEUTICALS, INC. | aveo-ex1016_388.htm |
| EX-4.5 - EX-4.5 - AVEO PHARMACEUTICALS, INC. | aveo-ex45_537.htm |
| EX-4.1 - EX-4.1 - AVEO PHARMACEUTICALS, INC. | aveo-ex41_444.htm |
| 10-K - 10-K - AVEO PHARMACEUTICALS, INC. | aveo-10k_20191231.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
|
Name |
|
Jurisdiction of Organization |
|
Percentage Ownership |
|
AVEO Pharma Limited |
|
United Kingdom |
|
100% |
|
AVEO Securities Corporation |
|
Massachusetts |
|
100% |
|
AVEO Pharma (Ireland) Limited |
|
Ireland |
|
100% |
|
|
||||